Table 1. Description of main study characteristics.
| Characteristics | Categories | Number (n); proportion (%) | Reference |
|---|---|---|---|
| Location | United States | n=5; 71.4% | Chu et al., 2021; Larkey et al., 2012; Ma et al., 2022; McDonough et al., 2016; Lee et al., 2018 |
| Iran | n=1; 14.3% | Khani Jeihooni et al., 2021 | |
| Nigeria | n=1; 14.3% | Olubodun et al., 2022 | |
| Study design | One-group quasi-experimental study | n=3; 42.9% | Chu et al., 2021; Ma et al., 2022; McDonough et al., 2016 |
| Non-equivalent quasi-experimental controlled study | n=2; 28.6% | Khani Jeihooni et al., 2021; Olubodun et al., 2022 | |
| Two-group quasi-experimental study | n=1; 14.3% | Larkey et al., 2012 | |
| Randomized controlled trial (RCT) | n=1; 14.3% | Lee et al., 2018 | |
| Interventions | Educational component | n=7; 100% | Chu et al., 2021; Khani Jeihooni et al., 2021; Larkey et al., 2012; Lee et al., 2018; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016 |
| Co-ethnic/speaks the same language as participants’ | n=6; 85.7% | Chu et al., 2021; Larkey et al., 2012; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016; Lee et al., 2018 | |
| HPV-related outcomes | Cervical cancer screening | n=5; 71.4% | Khani Jeihooni et al., 2021; Larkey et al., 2012; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016 |
| HPV immunization | n=2; 28.6% | Chu et al., 2021; Lee et al., 2018 | |
| Social capital dimensions | Cognitive | n=7, 100% | Chu et al., 2021; Khani Jeihooni et al., 2021; Larkey et al., 2012; Lee et al., 2018; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016 |
| Structural | n=2; 28.6% | Lee et al., 2018; Olubodun et al., 2022 | |
| Social capital functions | Bonding | n=7, 100% | Chu et al., 2021; Khani Jeihooni et al., 2021; Larkey et al., 2012; Lee et al., 2018; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016 |
| Bridging | n=7, 100% | Chu et al., 2021; Khani Jeihooni et al., 2021; Larkey et al., 2012; Lee et al., 2018; Ma et al., 2022; Olubodun et al., 2022; McDonough et al., 2016 | |
| Linking | n=5; 71.4% | Khani Jeihooni et al., 2021; Larkey et al., 2012; Lee et al., 2018; Olubodun et al., 2022; McDonough et al., 2016 |
Abbreviation: HPV, human papillomavirus